Eligibility for Anti-Amyloid Therapies in Patients With Biomarker-Confirmed Atypical Alzheimer Disease Phenotypes

Neurology · Published 2026-08-05 · DOI 10.1212/wnl.0000000000218347

Free full text

Authors (11)

Dror Shir, Nick Corriveau-Lecavalier, David T. Jones, Vijay K. Ramanan, Christian Lachner, David S. Knopman, Ronald C. Petersen, Keith Anthony Josephs, Gregory S. Day, Jonathan Graff-Radford, Neill R. Graff-Radford

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Shir, D., Corriveau-Lecavalier, N., Jones, D., et al. (2026). Eligibility for Anti-Amyloid Therapies in Patients With Biomarker-Confirmed Atypical Alzheimer Disease Phenotypes. Neurology. https://doi.org/10.1212/wnl.0000000000218347

Related articles

• The Challenge of Atypical Alzheimer Disease Phenotypes · Neurology · 2026 · Cites or is cited by this article · Same journal
• Mechanism-Based Therapy With Ampreloxetine for Neurogenic Orthostatic Hypotension in Multiple System Atrophy · Neurology · 2026 · Same journal
• Convulsions, Palsy, and the Spanish Inquisition · Neurology · 2026 · Same journal
• Natural History of Adult-Onset Myotonic Dystrophy Type 1 · Neurology · 2026 · Same journal
• Rate of Autoimmune Diseases in the 10 Years Preceding Myasthenia Gravis Diagnosis · Neurology · 2026 · Same journal
• Child Neurology: Early-Onset, Rapidly Progressive, and Refractory DYT- TOR1A Status Dystonicus · Neurology · 2026 · Same journal
• Teaching NeuroImage: Utility of Arterial Spin Labeling in Detecting Occult Micro-AVM in Angiogram-Negative Acute ICH · Neurology · 2026 · Same journal
• Antiseizure Medication Dosing Strategy During Pregnancy and Early Postpartum in Women With Epilepsy in MONEAD · Neurology · 2026 · Same journal
• Central Obesity and Recurrent Cardiovascular Events in Patients With Obstructive Sleep Apnea · Neurology · 2026 · Same journal
• Vamorolone for Duchenne Muscular Dystrophy · Neurology · 2026 · Same journal